Role of aminergic (serotonin and dopamine) systems in the embryogenesis and different embryonic behaviors of the pond snail, Lymnaea stagnalis.
A detailed biochemical and pharmacological analysis of the dopaminergic (DAergic) and serotonergic (5-HTergic) systems was performed during the embryogenesis of Lymnaea stagnalis, to monitor their role in development and different behaviors. The dopamine (DA) level and the synthesizing decarboxylase enzyme activity showed a continuous increase, whereas the serotonin (5-HT) concentration remained low until late postmetamorphic development, when they all showed a rapid and significant increase. Application of monoamine precursors increased, whereas enzyme inhibitors and neurotoxins reduced monoamine levels; all treatments resulting in a prolongation of embryogenesis. Following, p-chlorphenylalanine (pCPA) and 3-hydroxybenzylhydrazine (Nsd-1015) treatments, no 5-HT immunoreactivity could be detected in the embryonic nervous system. These findings suggest that changes of monoamine levels in either (negative or positive) direction cause slowing of embryogenesis. Embryonic rotation and radula protrusion rate was enhanced following both serotonin and dopamine application, whereas frequency of gliding was increased by serotonin treatment. These results clearly indicate the involvement of 5-HT and DA in the regulation of a broad range of embryonic behaviors. Pharmacological characterization of a 5-HT receptor associated with the L. stagnalis embryonic behaviors studied revealed that a mammalian 5-HT(1)-like receptor type is involved in the 5-HTergic regulation of locomotion activity.
Filla
Adrienn
A
Department of Experimental Zoology, Balaton Limnological Research Institute, Hungarian Academy of Science, Tihany, Hungary.
Hiripi
László
L
Elekes
Károly
K
D000818:Animals; D001142:Aromatic-L-Amino-Acid Decarboxylases / Q000378:metabolism; D002923:Cilia / Q000378:metabolism; D004296:Dopa Decarboxylase / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism*; D015259:Dopamine Agents / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004625:Embryo, Nonmammalian / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005247:Feeding Behavior; D007150:Immunohistochemistry; D008124:Locomotion; D008195:Lymnaea / Q000187:drug effects / Q000196:embryology / Q000378:metabolism*; D009498:Neurotoxins / Q000494:pharmacology; D044263:Receptors, Serotonin, 5-HT1 / Q000378:metabolism; D012399:Rotation; D012701:Serotonin / Q000378:metabolism*; D018490:Serotonin Agents / Q000494:pharmacology; D015398:Signal Transduction / Q000187:drug effects; D013997:Time Factors
D015259:Dopamine Agents; D004791:Enzyme Inhibitors; D009498:Neurotoxins; D044263:Receptors, Serotonin, 5-HT1; D018490:Serotonin Agents; D012701:Serotonin; D004296:Dopa Decarboxylase; D001142:Aromatic-L-Amino-Acid Decarboxylases; D004298:Dopamine